GitVibes daily briefing · 2026-10-08 · human
Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
Curated by Kripa
Perspective
I wonder if learning that blocking the P2X7 receptor reduces inflammation could be a first step for developers interested in drug‑repurposing ideas.
Source summary
Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.
Original reporting: ScienceDaily · Published 2026-10-07